Huangqi Decoction Attenuates Renal Interstitial Fibrosis Transforming Growth Factor-β1/mitogen-activated Protein Kinase Signaling Pathways in 5/6 Nephrectomy Mice
Overview
Affiliations
Objective: To investigate the effect of Huangqi decoction on renal interstitial fibrosis and its association with the transforming growth factor-β1 (TGF-β1) / mitogen-activated protein kinase (MAPK) signaling pathway.
Methods: 120 C57/BL mice were randomly divided into six groups: sham group, Enalapril (20 mg/kg) group, 5/6 nephrectomy model group, and 5/6 nephrectomy model plus Huangqicoction (0.12, 0.36 and 1.08 g/kg respectively) groups. Detecting 24hours urinary protein, blood pressure, serum creatinine, urea nitrogen content changes. Periodic Acid-Schiff stain (PAS) and Masson's trichrome staining was used to observe the renal tissue pathological changes. Protein expression of TGF-β1, Phosphorylated P38 mitogen activated protein kinases (P-P38), Phosphorylated c-jun N-terminal kinase (P-JNK), Phosphorylated extracellular regulated proteinhnase (P-ERK), Fibroblast-specific protein-1 (FSP-1), Alpha smooth muscle actin (α-SMA), Type III collagen (Collagen III), Connective tissue growth factor (CTGF), Bcl-2 Assaciated X protein (Bax) and B cell lymphoma 2 (Bcl-2) were measured with western blot and immunohistochemical.
Results: Both Huangqi decoction and Enalapril improved the kidney function, 24 h urinary protein and the fibrosis in 5/6 nephrectomy mice, Huangqi decoction downregulated the expressions of TGF-β1, FSP-1, α-SMA, Collagen III and CTGF in a dose-dependent manner, and it has a significant difference ( 0.01) compared with model group.Huangqi decoction downregulated the expressions of P-P38, P-JNK, P-ERK and Bcl-2 in a dose-dependent manner, while upregulated the expression of Bax.
Conclusions: The protective effect of Huangqi decoction for renal interstitial fibrosis in 5/6 nep-hrectomized mice the inhibition of Epithelial-Mesenchymal Transitions and downregulating the TGF-β1/ MAPK signaling pathway.
Gedi Z, Gengxin L, Min G, Fuli L, Ziyou Y, Wei G J Tradit Chin Med. 2024; 44(5):934-943.
PMID: 39380224 PMC: 11462534. DOI: 10.19852/j.cnki.jtcm.20231231.001.
Research progress on the application of Chinese herbal medicine in anal fistula surgery.
Kang Z, Yu Y Am J Transl Res. 2024; 16(8):3519-3533.
PMID: 39262715 PMC: 11384414. DOI: 10.62347/DZHK5180.
Yu W, Zeng C, Wang C, Jia S, Liu C, Zeng Y Cell Biochem Biophys. 2024; 82(2):927-943.
PMID: 38722471 DOI: 10.1007/s12013-024-01244-6.